Real Time continuous glucose monitoring in the newborn
Research type
Research Study
Full title
Real Time continuous glucose monitoring in the newborn (feasibility)
IRAS ID
150193
Contact name
Kathryn Beardsall
Contact email
Sponsor organisation
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
Research summary
Increasing numbers of infants are born preterm, with significant risk of mortality and morbidity. Interventions to improve clinical outcomes have been difficult to identify. High and low blood sugar levels are a common problem in these babies,and are difficult to manage, and have also been associated with increased mortality and morbidity. They may therefore be important modifiable risk factors to improve clinical outcomes. Controlling blood sugars in the newborn is challenging due to i) the infrequent nature of checking sugar levels because of the size and sickness of babies ii) the very variable response babies have to treatment. Real time continuous glucose monitors (rCGM) provide a continuous read out of sugar levels without having to disturb a baby. We will undertake a feasibility study to evaluate the clinical role for rCGM in the high risk preterm infant to inform the design of a multicentre randomised controlled trial.
REC name
East of England - Cambridge Central Research Ethics Committee
REC reference
14/EE/0127
Date of REC Opinion
24 Apr 2014
REC opinion
Favourable Opinion